3) Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41:3972-8.
4) Bhatt LK, Addepalli V. Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats. Am J Transl Res 2010;2:181-9.
5) Das A, McLamore A, Song W, McGuire PG. Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch Ophthalmol 1999;117:498-503.
8) Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477:267-83.
11) Ajith TA; Ranimenon. Homocysteine in ocular diseases. Clin Chim Acta 2015;450:316-21.
16) Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991;32:172-80.
17) Pang IH, Helberg PE, Fleenor DL, et al. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2003;44:3485-93.
18) Becker B. Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson memorial lecture. Am J Ophthalmol 1971;71:1-16.
19) Davies PD, Duncan G, Pynsent PB, et al. Aqueous humour glucose concentration in cataract patients and its effect on the lens. Exp Eye Res 1984;39:605-9.
20) Lin Z, Huang S, Yu H, et al. Analysis of plasma hydrogen sulfide, homocysteine, and L-cysteine in open-angle glaucoma patients. J Ocul Pharmacol Ther 2020;36:649-57.
21) Choo BJ, Hwang YH, Lee JH, Kim TJ. Comparison of serum homocysteine, vitamin B12, vitamin B6 and folate levels in different glaucoma types. J Korean Ophthalmol Soc 2013;54:104-11.
22) Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 1984;91:564-79.
23) Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
25) Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995;184:39-51.
27) Srivastav K, Saxena S, Mahdi AA, et al. Increased serum level of homocysteine correlates with retinal nerve fiber layer thinning in diabetic retinopathy. Mol Vis 2016;22:1352-60.
31) Olson MW, Gervasi DC, Mobashery S, Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 1997;272:29975-83.
32) Stamer WD, Clark AF. The many faces of the trabecular meshwork cell. Exp Eye Res 2017;158:112-23.
33) Alexander JP, Samples JW, Van Duskirk EM, Acott TS. Expression of matrix metolloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991;32:172-80.
34) Pang IH, Hellberg PE, Fleenor DL, et al. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2003;44:3485-93.
35) Nguyen KP, Chung ML, Anderson PJ, et al. Hydrogen peroxide removal by the calf aqueous outflow pathway. Invest Ophthalmol Vis Sci 1988;29:976-81.